Clinical study on efficacy of alendronate infusion for pediatric osteogenesis imperfecta (including severe form)
Not Applicable
- Conditions
- osteogenesis imperfecta
- Registration Number
- JPRN-UMIN000010615
- Lead Sponsor
- Tohoku University School of Medicine, Department of Pediatrics
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up continuing
- Sex
- All
- Target Recruitment
- 10
Inclusion Criteria
Not provided
Exclusion Criteria
-Patients with the following diseases which show fracture easily: Juvenile osteoporosis, hypophosphatasia, Ehlers-Danlos syndrome, Osteoporosis-pseudoglioma syndrome, Bruck syndrome. -Patients with osteogenesis imperfecta who falls under any of the following conditions shall be excluded: 1)Patients previously treated with any medical treatment including bisphosphonates 2)Patients with severe renal dysfunction 3)Patients with severe brain complication such as intracranial hemorrhage 4)Patients with congenital heart disease
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method